about
Hepatocellular carcinoma: Where are we?Hepatobiliary Tumors: Update on Diagnosis and ManagementDual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinomaMortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesHCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaCombining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report.Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis.The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma.The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis.Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas.Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
P2860
Q26765182-7C80FFCA-FD68-43D3-95A0-5A26ABB3A113Q26775654-5B3B105F-6424-4FBE-8C65-49050AC04955Q36747536-AE6476DD-8A18-45AD-ACCE-B576386CE6CDQ37606333-1FFC5FD2-8D1B-4BF8-93BF-C8CF143188CDQ38935703-69F2FCBC-BBCE-454A-ACBC-9B3C849AE487Q38976824-C5361A30-94EA-49D9-944F-E170B7B24376Q39067623-CA46EFC5-B668-4808-A94E-35F2ACD02E2CQ39296532-31381767-14F4-48E9-ABDA-F23B5203ED4AQ39366700-2C7D1683-E018-4C50-B2A8-7D842A655086Q39552999-6BBD1021-C577-4470-A95D-8B5310FDCE0CQ41706815-517CFB9F-579C-46E0-AE01-077587B351D5Q42620760-93A95DD8-4CF2-48A2-8823-407EE3CD3AD2Q42760402-628161A0-D06D-4B6D-BC39-A15A8BA1D523Q47193640-57F4CC55-12C2-4056-8696-298939062525Q48157080-DDC8E974-3FE9-4FD5-B258-F442DCFD15FDQ48350251-DFC9A01C-0CC3-4E55-83E3-32583D2794A9Q50072148-D339A190-67F5-4AF9-AB84-F8B15835D063Q54247807-95284A8B-0D03-443B-8643-CAC7EF143583Q55058147-918616A5-7619-402C-8EA9-5CF45EACFE99Q55506760-788EF088-4E7A-4A24-9257-FD1A4C1701A1
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Surgical management of hepatocellular carcinoma.
@en
type
label
Surgical management of hepatocellular carcinoma.
@en
prefLabel
Surgical management of hepatocellular carcinoma.
@en
P2860
P356
P1476
Surgical management of hepatocellular carcinoma
@en
P2093
Tony Cy Pang
P2860
P304
P356
10.4254/WJH.V7.I2.245
P577
2015-02-01T00:00:00Z